Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar CramersSkeeDaddy (98.67) Submitted: 10/13/2010 12:01:39 PM : Outperform Start Price: $34.08 ALXN Score: +158.01

biotech spec 3

Featured Broker Partners


Advertisement